Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Peregrine Pharmaceuticals Company Profile (NASDAQ:PPHM)

Consensus Ratings for Peregrine Pharmaceuticals (NASDAQ:PPHM) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.50 (345.21% upside)

Analysts' Ratings History for Peregrine Pharmaceuticals (NASDAQ:PPHM)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/15/2014Roth CapitalReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
3/11/2014MLV & Co Boost Price TargetBuy$2.50 -> $3.50ViewTweet This Rating  Share This Rating on StockTwits
1/17/2014JPMorgan Chase & Co.Lower Price Target$12.00 -> $9.50ViewTweet This Rating  Share This Rating on StockTwits
6/28/2013Roth CapitalLower Price Target$7.00 -> $5.00ViewTweet This Rating  Share This Rating on StockTwits
6/3/2013Roth CapitalBoost Price TargetBuy$4.00 -> $7.00ViewTweet This Rating  Share This Rating on StockTwits
3/5/2013Piper JaffrayInitiated CoverageOverweight$2.50ViewTweet This Rating  Share This Rating on StockTwits
1/7/2013Roth CapitalUpgradeNeutral -> Buy$2.70ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/18/2012 forward)